DMT is one of the most mysterious compounds on Earth. Smoke it and you find yourself in a alien reality full of impossibly complex pattersn, structures and even entities. But between five and twenty minutes later, you’re back in the “real world”. That brevity has always been part of the mythology, and part of the frustration. You break through, are filled with awe at what you are experiencing, and then the door closes before you’ve had time to really get to grips with the realm.
Eleusis, which opened earlier this year on the island of Bequia in Saint Vincent and the Grenadines, is is offering a way to keep that door open, for over 2 hours. Billed as the world’s first legal, medically supervised luxury psychedelic immersion center, Eleusis is the commercial debut of a technology called DMTx, which uses a continuous, target-controlled IV infusion to stretch the traditional DMT peak from minutes into a sustained state that can last hours.
The science behind the stretch
DMTx is the applied version of an idea Andrew Gallimore and Rick Strassman proposed years ago. If you could keep brain DMT concentrations at a stable plateau instead of letting them spike and crash, you could turn a usually fleeting encounter into a sustained one.
The protocol works by delivering a bolus injection to rapidly raise DMT to the target level, followed by a slow constant-rate infusion that fights off the compound’s famously fast metabolism. In a study out of Imperial College London led by Chris Timmermann, eleven healthy volunteers went through this combined bolus-and-infusion protocol at escalating doses, with each session spaced weeks apart. The subjective intensity plateaued into a steady state even as plasma DMT levels kept climbing, which is itself an interesting finding. Something in the brain seems to cap how “loud” the experience gets, independent of how much drug is on board.
A few results from that research stand out. Entity encounters, immersion, and visual complexity all increased with dose, which tracks with decades of DMT trip reports. But ego dissolution stayed low even at the highest doses, which is a departure from what happens with psilocybin or LSD or psilocybin at high doses, where the dissolving of self-boundaries tends to scale with intensity.
There was also a hint of short-term psychological tolerance. Participants described the experience as similarly intense across the infusion window even as drug levels rose, suggesting a kind of habituation kicks in fast. And oddly, entity encounters seemed to intensify around the ten-minute mark, well past where a standard bolus trip would already be fading. Whatever is happening in extended-state DMT, it isn’t just “the same trip, longer.”
Timmermann’s earlier combined fMRI-EEG work at Imperial gives some of the mechanistic backdrop here. Under DMT, the brain shows a marked increase in global connectivity, a kind of network disintegration where regions that don’t normally talk much start cross-communicating heavily, especially in the higher-level systems involved in prediction and imagination. The working theory is that DMT disrupts the brain’s normal job of modeling the world, and what rushes in to fill that gap is the DMT state itself.
The lab to the Caribbean
Eleusis is where this research leaves the institution and becomes an experience anyone can book. Founded by Christina Thomas, Angus Taylor, Charles Patti, and Craig Stenhouse, the center describes itself deliberately as not a clinic, not a wellness product, and not a retreat. It’s a research immersion for experienced participants, run inside a private tropical compound with ten villas, physician oversight, EEG and biometric tracking, and a low-inflammation, farm-to-table food program built around the same “prepare the terrain” logic that shows up everywhere else in functional medicine.
DMTx protocols at Eleusis are administered by a trained medical team with structured screening, preparation, and integration built around the infusion itself, not bolted on afterward. Gallimore, who invented the DMTx protocol, is on the team directly, alongside Timmermann as director of research and a roster that spans psychiatry, nursing, and performance neuroscience.
Eleusis also frames its offering around two structured programs rather than a single generic “trip.” Flow uses EEG feedback to help participants build flow-state skills for leadership and creative work. Create is oriented toward translating whatever surfaces during the extended state into tangible output, whether that’s visual art, music, or design.
DMTx experiments
In the last few weeks, it’s been announced that Gallimore has teamed up with Donald Hoffman, the UC Irvine cognitive scientist known for arguing that perception functions like a user interface rather than a window onto raw reality, plus mathematician Niffe Hermansson, to ask a fascinatong question: are the entities encountered on DMT just internally generated hallucinations or conscious agents (ie. real)?
Their preprint, “Traces of the Other, Are DMT Entities Real?“, builds on Hoffman’s framework of conscious realism, the idea that reality is fundamentally made of interacting conscious agents, and that space, time, and objects are more like icons on a desktop than the code running underneath. Under that framework, perception is a species-specific interface that only shows you the thin slice of reality evolution needed you to see, and everything else gets filtered out as noise. Gallimore, Hoffman, and Hermansson formalize this into a mathematical model (an agent navigating a space of possible conscious states via something they call a qualia kernel) and, crucially, use it to generate testable predictions rather than just a compelling metaphor.
This is where DMTx comes in. A three-to-five-minute bolus trip gives you no time to run an experiment. You barely have time to be astonished before you’re back in the room. DMTx, extending the state to an hour or more is what makes it possible to send trained observers into that space with a protocol in hand, adjust dosage as needed, and actually look for structured “traces” of something other than the observer’s own cognition.
Noonautics, Gallimore’s research non-profit, and the Trace Institute, Hoffman’s outfit, are now planning to run exactly these experiments, and Eleusis, with its physician-supervised infusion capability already built out on Bequia, is a natural place for that kind of controlled, sustained-state research to actually happen.
Whatever the outcome, the goal is falsifiability. Either the data will support the hallucination-only account, in which case we’ll have learned something real about how the brain manufactures apparently autonomous minds out of nothing, or it won’t, in which case we’re looking at one of the strangest findings in the history of consciousness research.
Frontier
DMT isn’t some obscure lab-synthesized exotic compound. It’s everywhere in nature, found in trace amounts across plants, animals, and even our own bodies. And since the early internet, anyone with a basic understanding of organic chemistry and a free afternoon has been able to extract it in a home kitchen.
That accessibility, combined with cheap global connectivity, has produced hundreds of thousands of trip reports posted to forums and subreddits over the last two decades, an enormous, uncoordinated citizen dataset describing the same handful of anomalous features again and again: the complexity, the “more real than real” quality, and, again and again, the entities.
For most of that time, there was no serious way to study any of it beyond collecting anecdotes. Now, in the space of a few years, we’ve gotten a medical protocol that can stretch the experience long enough to actually run experiments inside it, and a mathematical framework serious enough to make specific, falsifiable predictions about what those experiments should find.
That’s an extraordinary coincidence of timing, or maybe not a coincidence at all. It genuinely feels like we’re standing at the edge of something that could reshape how consciousness research gets done, and possibly how we think about the boundary between self and world altogether. I don’t think it’s an overstatement to call this one of the most exciting corners of science happening anywhere right now.
If you want to see experience DMTx for yourself, Eleusis is accepting applications. Find out more and apply at eleusismind.com.
Keep up with the research here.
